questionsmedicales.fr
Maladies du système stomatognathique
Maladies de la bouche
Maladies parodontales
Atrophie parodontale
Atrophie parodontale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Atrophie parodontale
Maladies parodontales
Sondage parodontal
Radiographie dentaire
Récession gingivale
Mobilité dentaire
Atrophie parodontale
Stabilisation
Antécédents médicaux
Facteurs de risque
Symptômes
5
Douleur dentaire
Mastication
Saignement gingival
Hygiène bucco-dentaire
Esthétique dentaire
Récession gingivale
Sensibilité dentaire
Atrophie parodontale
Prévention
5
Hygiène bucco-dentaire
Visites dentaires
Plaque dentaire
Brossage des dents
Rinçage buccal
Inflammation gingivale
Nutrition
Santé gingivale
Tabagisme
Maladies parodontales
Traitements
5
Détartrage
Chirurgie parodontale
Chirurgie parodontale
Restauration
Antibiotiques
Infections parodontales
Thérapie au laser
Inflammation
Anesthésie
Inconfort dentaire
Complications
5
Perte dentaire
Infections
Santé systémique
Maladies parodontales
Diabète
Contrôle glycémique
Qualité de vie
Estime de soi
Facteurs de risque
5
Stress
Système immunitaire
Maladies auto-immunes
Atrophie parodontale
Nutrition
Santé gingivale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Atrophie parodontale : Questions médicales les plus fréquentes",
"headline": "Atrophie parodontale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Atrophie parodontale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Atrophie parodontale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies parodontales",
"url": "https://questionsmedicales.fr/mesh/D010510",
"about": {
"@type": "MedicalCondition",
"name": "Maladies parodontales",
"code": {
"@type": "MedicalCode",
"code": "D010510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Résorption alvéolaire",
"alternateName": "Alveolar Bone Loss",
"url": "https://questionsmedicales.fr/mesh/D016301",
"about": {
"@type": "MedicalCondition",
"name": "Résorption alvéolaire",
"code": {
"@type": "MedicalCode",
"code": "D016301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récession gingivale",
"alternateName": "Gingival Recession",
"url": "https://questionsmedicales.fr/mesh/D005889",
"about": {
"@type": "MedicalCondition",
"name": "Récession gingivale",
"code": {
"@type": "MedicalCode",
"code": "D005889",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perte d'attache parodontale",
"alternateName": "Periodontal Attachment Loss",
"url": "https://questionsmedicales.fr/mesh/D017622",
"about": {
"@type": "MedicalCondition",
"name": "Perte d'attache parodontale",
"code": {
"@type": "MedicalCode",
"code": "D017622",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Atrophie parodontale",
"alternateName": "Periodontal Atrophy",
"code": {
"@type": "MedicalCode",
"code": "D055093",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Frederik Barkhof",
"url": "https://questionsmedicales.fr/author/Frederik%20Barkhof",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden."
}
},
{
"@type": "Person",
"name": "Maria Teresa Pellecchia",
"url": "https://questionsmedicales.fr/author/Maria%20Teresa%20Pellecchia",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", Neuroscience Section, University of Salerno, Baronissi, SA, Italy."
}
},
{
"@type": "Person",
"name": "Iva Stankovic",
"url": "https://questionsmedicales.fr/author/Iva%20Stankovic",
"affiliation": {
"@type": "Organization",
"name": "Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia."
}
},
{
"@type": "Person",
"name": "Gregor K Wenning",
"url": "https://questionsmedicales.fr/author/Gregor%20K%20Wenning",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria."
}
},
{
"@type": "Person",
"name": "Klaus Seppi",
"url": "https://questionsmedicales.fr/author/Klaus%20Seppi",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Completeness of variables in Hospital-Based Cancer Registries for prostatic malignant neoplasm.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39082550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0034-7167-2023-0467"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18 F-DCFPyl PET/CT.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36728165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36572885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-022-02841-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of prostate volume on clinical parameters in prostate cancer screening.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36098911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcla.24700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système stomatognathique",
"item": "https://questionsmedicales.fr/mesh/D009057"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la bouche",
"item": "https://questionsmedicales.fr/mesh/D009059"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies parodontales",
"item": "https://questionsmedicales.fr/mesh/D010510"
},
{
"@type": "ListItem",
"position": 5,
"name": "Atrophie parodontale",
"item": "https://questionsmedicales.fr/mesh/D055093"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Atrophie parodontale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Atrophie parodontale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Atrophie parodontale",
"description": "Comment diagnostiquer l'atrophie parodontale ?\nQuels tests sont utilisés pour évaluer l'atrophie ?\nQuels signes cliniques indiquent l'atrophie ?\nL'atrophie parodontale est-elle réversible ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Atrophie parodontale",
"description": "Quels sont les symptômes de l'atrophie parodontale ?\nL'atrophie parodontale cause-t-elle des douleurs ?\nPeut-on avoir des gencives qui saignent ?\nComment l'atrophie affecte-t-elle l'apparence des dents ?\nY a-t-il un lien entre l'atrophie et la sensibilité dentaire ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Atrophie parodontale",
"description": "Comment prévenir l'atrophie parodontale ?\nQuel rôle joue le brossage des dents ?\nLes produits de rinçage buccal sont-ils utiles ?\nL'alimentation influence-t-elle la santé parodontale ?\nFumer affecte-t-il la santé parodontale ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Atrophie parodontale",
"description": "Quels traitements sont disponibles pour l'atrophie parodontale ?\nLa chirurgie est-elle nécessaire pour traiter l'atrophie ?\nLes antibiotiques sont-ils utilisés dans le traitement ?\nComment la thérapie au laser aide-t-elle ?\nLes traitements sont-ils douloureux ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Atrophie parodontale",
"description": "Quelles complications peuvent survenir avec l'atrophie ?\nL'atrophie parodontale peut-elle affecter la santé générale ?\nY a-t-il un risque accru de diabète ?\nComment l'atrophie affecte-t-elle la qualité de vie ?\nLes infections parodontales peuvent-elles se propager ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Atrophie parodontale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'atrophie ?\nLe stress a-t-il un impact sur la santé parodontale ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nUne alimentation déséquilibrée influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'atrophie parodontale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un examen clinique et des radiographies dentaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'atrophie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des sondages parodontal et des radiographies sont utilisés pour évaluer la perte osseuse."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent l'atrophie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent la récession gingivale et la mobilité dentaire."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale est-elle réversible ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'atrophie parodontale est généralement irréversible, mais peut être stabilisée."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les facteurs de risque et les antécédents de maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'atrophie parodontale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des gencives enflammées, des douleurs et une mauvaise haleine."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs lors de la mastication ou de la pression sur les dents."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des gencives qui saignent ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les gencives peuvent saigner lors du brossage ou de l'utilisation de fil dentaire."
}
},
{
"@type": "Question",
"name": "Comment l'atrophie affecte-t-elle l'apparence des dents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner un aspect plus long des dents en raison de la récession gingivale."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'atrophie et la sensibilité dentaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'atrophie peut augmenter la sensibilité dentaire aux aliments chauds ou froids."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'atrophie parodontale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste sont essentielles."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le brossage des dents ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le brossage régulier aide à éliminer la plaque dentaire et à prévenir les maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les produits de rinçage buccal sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains rince-bouche antibactériens peuvent aider à réduire l'inflammation gingivale."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé parodontale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée riche en vitamines et minéraux favorise la santé des gencives."
}
},
{
"@type": "Question",
"name": "Fumer affecte-t-il la santé parodontale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de maladies parodontales et d'atrophie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'atrophie parodontale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent le détartrage, le surfaçage radiculaire et la chirurgie parodontale."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire pour traiter l'atrophie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être nécessaire dans les cas avancés pour restaurer le tissu parodontal."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utilisés dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques peuvent être prescrits pour traiter les infections parodontales."
}
},
{
"@type": "Question",
"name": "Comment la thérapie au laser aide-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie au laser peut réduire l'inflammation et favoriser la guérison des tissus parodontal."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils douloureux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent causer un certain inconfort, mais des anesthésiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'atrophie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de dents, des infections et des problèmes de mastication."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale peut-elle affecter la santé générale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent un lien entre les maladies parodontales et des problèmes systémiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies parodontales peuvent aggraver le contrôle glycémique chez les diabétiques."
}
},
{
"@type": "Question",
"name": "Comment l'atrophie affecte-t-elle la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des douleurs, des difficultés à manger et une baisse de l'estime de soi."
}
},
{
"@type": "Question",
"name": "Les infections parodontales peuvent-elles se propager ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent se propager à d'autres parties du corps, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, le diabète, et une mauvaise hygiène bucco-dentaire."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'atrophie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'atrophie parodontale augmente avec l'âge en raison de l'usure des tissus."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la santé parodontale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et aggraver les maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'atrophie parodontale."
}
},
{
"@type": "Question",
"name": "Une alimentation déséquilibrée influence-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en nutriments peut affaiblir les gencives et favoriser l'atrophie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Baronissi, SA, Italy.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Division of Periodontology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Department of Periodontology, Endodontology and Cariology, University Centre for Dental Medicine, University of Basel, Basel, Switzerland.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
Periodontology Clinical Trials Group, University of Bristol, Bristol, UK.
Publications dans "Atrophie parodontale" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Oral Disease, West China Hospital of Stomatology, National Clinical Research Center for Oral Diseases, Sichuan University, Chengdu, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Neuro-Oncological Surgery, Neurosurgery Center, Zhujiang Hospital of Southern Medical University, Guangzhou, China. zyn1007@126.com.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Division of Pediatric Ophthalmology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Division of Pediatric Ophthalmology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Publications dans "Atrophie parodontale" :
1 publication dans cette catégorie
Affiliations :
Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Publications dans "Atrophie parodontale" :
to analyze the completeness of variables from Hospital-Based Cancer Registries of cases of prostate neoplasm in the Oncology Care Network of a Brazilian state between 2000 and 2020....
an ecological time series study, based on secondary data on prostate cancer Hospital-Based Cancer Registries prostate. Data incompleteness was classified as excellent (<5%), good (between 5%-10%), fai...
there were 13,519 cases of prostate cancer in the Hospital-Based Cancer Registries analyzed. The variables "family history of cancer" (p<0.001), "alcoholism" (p<0.001), "smoking" (p<0.001), "TNM stagi...
most Hospital-Based Cancer Registries variables showed excellent completeness, but important variables had high percentages of incompleteness, such as TNM and clinical staging, in addition to alcoholi...
18 F-DCFPyl is a Food and Drug Administration-approved radiotracer that targets prostate-specific membrane antigen and is used in the detection of recurrent or metastatic prostate cancer. As its use h...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
The optimal treatment of metastatic castration-resistant prostate cancer (mCRPC) continues to be challenging, given the multitude of life prolonging treatment options. Radionuclide therapy delivers co...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...